HR 3584 117th Congress House Government Operations and Politics Advisory bodies Business expenses Buy American requirements Cardiovascular and respiratory health Congressional operations and organization Congressional oversight Emergency medical services and trauma care Emergency planning and evacuation Government studies and investigations Health facilities and institutions Health technology, devices, supplies Income tax deductions Infectious and parasitic diseases Manufacturing Military procurement, research, weapons development Prescription drugs Presidents and presidential powers, Vice Presidents Public contracts and procurement State and local government operations

Made in America Emergency Preparedness Act

Introduced: May 28, 2021 Introduced by: Fitzpatrick, Brian K. Republican · Pennsylvania See on congress.gov

Everywhere this bill has been 5 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 1, 2021

Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.

May 31, 2021

Referred to the Subcommittee on Health.

May 31, 2021

Referred to the Subcommittee on Oversight, Management, and Accountability.

May 28, 2021

Referred to the Committee on Transportation and Infrastructure, and in addition to the Committees on Ways and Means, Oversight and Reform, Homeland Security, Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 28, 2021

Introduced in House

Plain-English summary Congressional Research Service

Made in America Emergency Preparedness Act

This bill establishes in the legislative branch the National Commission on United States Preparedness for National Emergencies and requires any medical, pharmaceutical, or emergency preparedness product deemed integral to a response to a national emergency to be manufactured and procured in the United States beginning on and after January 1, 2026.

The commission must, among other things, examine and report on the COVID-19 pandemic in the United States in 2020 and the private sector response, investigate the origin of the COVID-19 virus and measures for mitigating the impacts of future physical and medical national disasters, determine what medical, pharmaceutical, and emergency preparedness products are deemed to be essential to emergency preparedness, and report on infrastructure or capability deficiencies in hospitals and medical centers.

States must implement the commission's findings or lose access to federal emergency preparedness funds.

The bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property (e.g., personal protective equipment) placed in service after 2020 and before 2027.

What's happening now June 1, 2021

Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.

Committees of jurisdiction 9